David D. Ørsted

Liraglutide and Renal Outcomes in Type 2 Diabetes

Johannes F.E. Mann, David D. Ørsted, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

Xiaohong R. Yang, Jenny Chang‐Claude, Ellen L. Goode et al. · JNCI Journal of the National Cancer Institute · 2010 · 716 citations · Full text

Medicine, Cancer Biology, Oncology +16

Elevated C-Reactive Protein Levels, Psychological Distress, and Depression in 73 131 Individuals

Marie Kim Wium‐Andersen, David D. Ørsted, Børge G. Nordestgaard · JAMA Psychiatry · 2012 · 489 citations

Veterinary Medicine, Psychiatry, Clinical Psychology +16

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

Annegien Broeks, Marjanka K. Schmidt, Mark E. Sherman et al. · Human Molecular Genetics · 2011 · 173 citations · Full text

Life Sciences, Genetics, Oncology +15

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial

John B. Buse, Stephen C. Bain, Johannes F.E. Mann et al. · Diabetes Care · 2020 · 169 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17